Stockscreener 앱 받기
1.65
0.61%
0.01
전일 마감가:
$1.64
열려 있는:
$1.58
하루 거래량:
32,392
Relative Volume:
0.15
시가총액:
$14.87M
수익:
$170.00K
순이익/손실:
$-16.35M
주가수익비율:
-0.8869
EPS:
-1.8605
순현금흐름:
$-13.66M
1주 성능:
-2.37%
1개월 성능:
+44.74%
6개월 성능:
-61.72%
1년 성능:
-21.80%
1일 변동 폭
$1.5637
$1.70
1주일 범위
$1.234
$1.71
52주 변동 폭
$0.9875
$5.07
Lisata Therapeutics Inc Stock (LSTA) Company Profile
명칭
Lisata Therapeutics Inc
전화
908-229-2590
주소
110 ALLEN ROAD, BASKING RIDGE
Compare LSTA vs VRTX, REGN, ARGX, MRNA, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LSTA
Lisata Therapeutics Inc
|
1.65 | 10.09M | 170.00K | -16.35M | -13.66M | -1.8605 |
VRTX
Vertex Pharmaceuticals Inc
|
546.12 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
827.72 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,033.15 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
145.55 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
210.02 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
Lisata Therapeutics Inc 주식(LSTA)의 최신 뉴스
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Lisata Therapeutics Inc. (NASDAQ: LSTA) Share Price, LSTA Stock News, LSTA Share Price & Updates - Kalkine
Lisata (LSTA) Trading Levels Update: Climbs 6.48% to $1.15 in the Latest Session; Technical Focus: $1.09 and $1.21 Define the Nearby Reference LevelsHull Moving Average - Vinanet
Enterprise value to EBITDA forward of Lisata Therapeutics, Inc. – FWB:8NE - TradingView
Lisata Therapeutics (LSTA) Drops 4.24% to $1.13, Approaching Critical SupportBlue Chip Entry Points - Vinanet
Enterprise value to EBITDA forward of Lisata Therapeutics, Inc. – SWB:8NE - TradingView
Enterprise value to EBIT forward of Lisata Therapeutics, Inc. – NASDAQ:LSTA - TradingView
Lisata Therapeutics (8NE) Q4 2023 Earnings ReportResults, Call & Slides - TipRanks
Lisata Therapeutics (LSTA) Slips 0.93% as Shares Hover Near Key Support at $1.02Money Flow - vinanet.vn
LISATA THERAPEUTICS, INC. 2026: Revenue $0 EPS ($0.32) — 10-Q Summary - TradingView
Lisata Therapeutics Announces Major Workforce Reduction and Retrenchment - The Globe and Mail
Lisata Therapeutics sues Kuva Labs, cuts 72% of workforce By Investing.com - Investing.com India
Lisata Therapeutics sues Kuva Labs, cuts 72% of workforce - Investing.com
Lisata Therapeutics, Inc. Continues to Evaluate Strategic Alternatives to Enhance Stockholder Value - marketscreener.com
Lisata Therapeutics (LSTA) Pursues Legal Action After Merger Ter - GuruFocus
Lisata Therapeutics, Inc. (LSTA) Files 8-K Announcing Retention Bonus Agreement With James Nisco - Minichart
Lisata Therapeutics Files Suit Against Kuva Labs, Reviews Strategic Alternatives and Cuts Workforce to Preserve Cash - Quiver Quantitative
Lisata Therapeutics, Inc. Implements a Reduction in Force, Eliminating Approximately 72% of Full-Time Employees - marketscreener.com
Lisata Therapeutics terminates Dr. Kristen K. Buck as EVP R&D & CMO; James Nisco awarded $200,000 retention bonus - TradingView
Lisata Therapeutics moves forward with legal action following Kuva merger termination - Proactive financial news
Lisata Therapeutics (LSTA) Drops 3.9% to $0.99 as Biotech Stock Presses Key SupportDividend Arbitrage - vinanet.vn
LSTA Q3 2025 Earnings: Narrower-than-Expected Loss Offers Modest Encouragement Despite Share DipEPS Surprise History - vinanet.vn
Lisata Therapeutics, Inc. Revenue Breakdown – NASDAQ:LSTA - TradingView
Kuva Labs (LSTA) ends Lisata cash-and-CVR tender offer after financing shortfall - Stock Titan
Lisata Therapeutics Inc (LSTA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Lisata Therapeutics Inc (LSTA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Lisata Therapeutics (LSTA) Terminates Merger Agreement with Kuva Labs Amid Financing Issues - GuruFocus
LSTA|Lisata Therapeutics Inc|Price:1.470|Chg%:-0.200 - TradingKey
Lisata Therapeutics Inc (LSTA) Valuation: PE, PB & Fair Value Analysis - TradingKey
Lisata Therapeutics Inc (LSTA) Cash Flow - TradingKey
Lisata Therapeutics Inc (LSTA) Institutional Confidence - TradingKey
TradingKey - TradingKey
Lisata Therapeutics (LSTA) Plunges 21%: Key Levels to WatchZero Gamma Level - po-news-eg.net
Lisata Therapeutics, Inc. Revenue Breakdown – LS:A3DWGC - TradingView
Lisata Therapeutics Shares Fall After Terminating Kuva Labs Deal - Moomoo
Lisata Therapeutics Terminates Merger Agreement With Kuva Labs On July 24, Says SEC Filing - TradingView
Lisata Therapeutics Ends Kuva Merger, Starts Strategic Review - TipRanks
Lisata Therapeutics Stock Falls After Hours: Here's Why - webull.com
Lisata Therapeutics Inc (LSTA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Lisata Therapeutics (LSTA) says Kuva tender meets conditions but financing not yet secured - Stock Titan
Kuva Labs, Inc. completed the acquisition of Lisata Therapeutics, Inc.. - marketscreener.com
Lisata Therapeutics (LSTA) Q4 2023 Earnings ReportResults, Call & Slides - TipRanks
Enterprise value to EBIT forward of Lisata Therapeutics, Inc. – LSE:0HS8 - TradingView
Lisata Therapeutics Amends Merger Agreement with Kuva Labs—Key Details from Latest 8-K Filing - Minichart
Enterprise value to EBITDA forward of Lisata Therapeutics, Inc. – LSE:0HS8 - TradingView
Lisata Therapeutics Extends Merger Timeline with Kuva Labs - TipRanks
Lisata Therapeutics, Kuva Labs Amend Merger Agreement to Extend Outside Date to July 21 - TradingView
Lisata (Nasdaq: LSTA) merger timeline with Kuva pushed to July 21 - Stock Titan
Lisata Therapeutics (LSTA) extends Kuva tender offer as 64.7% of shares tendered - Stock Titan
Lisata Therapeutics (LSTA) tender offer extended as Kuva reports 64.67% tendered - Stock Titan
Lisata Therapeutics (LSTA) extends $4 cash-plus-CVR tender to July 16 - Stock Titan
Lisata Therapeutics Inc (LSTA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.86%
0.31%
자본화:
|
볼륨(24시간):